ALEMBICLTD
Pharmaceuticals & Drugs
₹66.8
0.00 (0.00%)
| Market Cap | 1,710 Cr | EPS | 3.1 | High | 67.5 | ||
| Stock P/E | 21.6 | Net Profit Margin | 12.7 | Low | 66.6 |
Performance
Today’s Low
Today’s High
66.6
67.5
52W Low
52W High
55.45
80.95
| Open Price | 67.5 | Volume | 2 |
| Prev. Close | 66.9 |
Fundamentals
| Market Cap | 1,710 Cr | ROE | 3.6% | ||
| P/E Ratio(TTM) | 21.6 | EPS(TTM) | 0.0 | ||
| P/B Ratio | 3.4 | Dividend Yield | 3.3% | ||
| Industry P/E | 59.1 | Book Value | 19.4 | ||
| Face Value | 2.0 |
About the Company
Alembic is a Public Limited Company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchanges in India. The registered office of the Company is located at Alembic Road, Vadodara, Gujarat. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.
Business area of the company
The company is primarily engaged in two businesses i.e.
API Manufacturing
- Estolate
- Biphenyl Valine Oxalate
- Venlafaxine
Real Estate
- Residential Projects
- Commercial Project
| Parent Organization | Alembic Ltd. | Managing Director | Malika C Amin | ||
| Founded | 1907 | NSE Symbol | ALEMBICLTD |
Financials
All values are in Rs Cr
Shareholding Pattern
Promoters
70.88%
Mutual Funds
4.63%
Foreign Institutions
1.12%
Domestic Institutions
4.69%
Promoters
70.88%
Mutual Funds
4.63%
Foreign Institutions
1.12%
Domestic Institutions
4.69%
Promoters
70.88%
Mutual Funds
4.63%
Foreign Institutions
1.12%
Domestic Institutions
4.69%
Promoters
70.88%
Mutual Funds
4.63%
Foreign Institutions
1.12%
Domestic Institutions
4.69%
Promoters
70.88%
Mutual Funds
4.63%
Foreign Institutions
1.12%
Domestic Institutions
4.69%
Peer Comparison
| Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
|---|---|---|---|---|---|
66.8(-0.1%) | 21.6 | ||||
411.9(-0.3%) | 30.9 | ||||
604.95(0.9%) | 41.1 | ||||
1271.4(-0.1%) | 39.9 |
